Literature DB >> 29553953

Robotic-assisted surgery in ophthalmology.

Marc D de Smet1,2, Gerrit J L Naus1, Koorosh Faridpooya3, Marco Mura4,5.   

Abstract

PURPOSE OF REVIEW: Provide an overview of the current landscape of robotics in ophthalmology, including the pros and cons of system designs, the clinical development path, and the likely future direction of the field. RECENT
FINDINGS: Robots designed for eye surgery should meet certain basic requirements. Three designs are currently being developed: smart surgical tools such as the steady hand, comanipulation devices and telemanipulators using either a fixed or virtual remote center of motion. Successful human intraocular surgery is being performed using the Preceyes surgical system. Another telemanipulation robot, the da Vinci Surgical System, has been used to perform a pterygium repair in humans and was successful in ex-vivo corneal surgery despite its nonophthalmic design. Apart from Preceyes' BV research platform, none of the currently eye-specific systems has reached a commercial stage. Systems are likely to evolve from robotic assistance during specific procedural steps to semiautonomous surgery, as smart sensors are introduced to enhance the basic functionalities of robotic systems.
SUMMARY: Robotics is still in its infancy in ophthalmology but is rapidly reaching a stage wherein it will be introduced into everyday ophthalmic practice. It will most likely be introduced first for demanding vitreo-retinal procedures, followed by anterior segment applications.

Entities:  

Mesh:

Year:  2018        PMID: 29553953     DOI: 10.1097/ICU.0000000000000476

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  15 in total

1.  A comparison of robotic and manual surgery for internal limiting membrane peeling.

Authors:  David A L Maberley; Maarten Beelen; Jorrit Smit; Thijs Meenink; Gerrit Naus; Clemens Wagner; Marc D de Smet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-02-03       Impact factor: 3.117

2.  Three-dimensional telesurgery and remote proctoring over a 5G network.

Authors:  Edward S Lu; Vincent S Reppucci; S K Steven Houston; Ashley L Kras; John B Miller
Journal:  Digit J Ophthalmol       Date:  2021-07-26

Review 3.  Robotic Surgery: A Narrative Review.

Authors:  Sakshi Bramhe; Swanand S Pathak
Journal:  Cureus       Date:  2022-09-15

4.  Robot-Assisted Simulated Strabismus Surgery.

Authors:  Tristan Bourcier; Jimmy Chammas; David Gaucher; Philippe Liverneaux; Jacques Marescaux; Claude Speeg-Schatz; Didier Mutter; Arnaud Sauer
Journal:  Transl Vis Sci Technol       Date:  2019-05-29       Impact factor: 3.283

5.  Toolkit for survival: How to run and manage ophthalmic practices during the difficult time of COVID-19 crisis.

Authors:  Suresh K Pandey; Vidushi Sharma
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

Review 6.  Endoscopic vitreoretinal surgery: principles, applications and new directions.

Authors:  Radwan S Ajlan; Aarsh A Desai; Martin A Mainster
Journal:  Int J Retina Vitreous       Date:  2019-06-18

Review 7.  Robotics and ophthalmology: Are we there yet?

Authors:  Suresh K Pandey; Vidushi Sharma
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

8.  The Effect of Haptic Feedback on Efficiency and Safety During Preretinal Membrane Peeling Simulation.

Authors:  Anibal Francone; Jason Mingyi Huang; Ji Ma; Tsu-Chin Tsao; Jacob Rosen; Jean-Pierre Hubschman
Journal:  Transl Vis Sci Technol       Date:  2019-07-03       Impact factor: 3.283

9.  Artificial intelligence, robotics and eye surgery: are we overfitted?

Authors:  Müller G Urias; Niravkumar Patel; Changyan He; Ali Ebrahimi; Ji Woong Kim; Iulian Iordachita; Peter L Gehlbach
Journal:  Int J Retina Vitreous       Date:  2019-12-16

10.  Robotic Retinal Surgery Impacts on Scleral Forces: In Vivo Study.

Authors:  Müller G Urias; Niravkumar Patel; Ali Ebrahimi; Iulian Iordachita; Peter L Gehlbach
Journal:  Transl Vis Sci Technol       Date:  2020-09-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.